GlassScriptPhysician profile
Dawn M Itzie
NPI 1194902791
$3,008.49
in general payments reported to CMS, 2019-2025
31 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $456 · 2022: $761 · 2023: $1,103 · 2024: $186 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,791.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $666.46 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $356.10 | 2021-2025 | Mounjaro, Emgality, Jardiance |
| Shield Therapeutics INC | $276.50 | 2023 | Accrufer |
| Astrazeneca Pharmaceuticals LP | $161.82 | 2021-2024 | Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.11 | 2021-2023 | Synjardy, Tradjenta, Jardiance |
| Pfizer INC. | $117.33 | 2021-2025 | |
| Esperion Therapeutics, INC. | $111.64 | 2021-2023 | Nexletol |
| Amgen INC. | $104.18 | 2021-2025 | Otezla, Repatha, Repatha |
| Abbvie INC. | $103.26 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $89.49 | 2022 | |
| Xeris Pharmaceuticals, INC. | $86.19 | 2023 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $76.88 | 2021-2025 | Lagevrio |
| Idorsia Pharmaceuticals US INC | $72.33 | 2022-2023 | Quviviq |
| Glaxosmithkline, LLC. | $67.97 | 2022-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbott Laboratories | $66.61 | 2023-2024 | Freestyle Libre 3 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $61.27 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $60.86 | 2022-2025 | |
| Dexcom, INC. | $57.41 | 2021-2023 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.92 | 2021-2023 | Xifaxan, Trulance |
| Exact Sciences Corporation | $31.50 | 2024-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $30.96 | 2023-2025 | Veozah |
| Edwards Lifesciences Corporation | $29.92 | 2025 | Sapien 3 Ultra Resilia |
| Organon LLC | $27.37 | 2025 | Nexplanon |
| Ani Pharmaceuticals, INC. | $26.63 | 2025 | Purified Cortrophin Gel |
| Actelion Pharmaceuticals US, INC. | $26.41 | 2025 | Opsumit, Uptravi |
| Dynavax Technologies Corporation | $22.92 | 2025 | Heplisav-B |
| Genzyme Corporation | $19.55 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.29 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.25 | 2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $16.72 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $13.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Itzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.